Beacon WebinarsÂ
Welcome to our comprehensive webinar resource page, your gateway to invaluable insights and expertise across our Beacon modalities. Here, you’ll find a collection of on-demand webinars, each thoughtfully crafted and delivered by our expert team. These webinars provide an abundant amount of commercial and research insights that serve to support your investment and drug development decisions.
Home > Webinar Resources
Upcoming Webinars
Watch Our Previous Sessions On Demand
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Cell-Therapy-4.png)
Webinar – The Future of Cell Therapies: An In-Depth Analysis of the 2023 Commercial and Research Landscape
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/GT-and-RNA.png)
Webinar – Realizing the Full Potential within the RNA and Gene Therapy Landscapes: 2023 So Far
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/GT-2-2.png)
Webinar – Gene Therapy: Optimizing the Safety of Viral Vectors
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/ADC-.png)
Webinar – The ADC Boom: Navigating the Expansive Landscape of Antibody-Drug Conjugates
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/BI-and-CP-1.png)
Webinar – Bispecific Antibodies and Immune Checkpoint Modulators: A H1 Landscape Analysis
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Cytokine-6.png)
Webinar – Examining the Cytokine-Based Drug Development Landscape: Interleukins and Beyond
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Microbiome-1-1.png)
Webinar – Unlocking the Value of Microbiome-Targeting Therapeutics in Combating Infectious Diseases
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Immune-Tolerance-1.png)
Webinar – T Cell Therapies: The Road Ahead for Addressing Autoimmune Indications
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/TPD-2-1.png)
Webinar – The TPD Disease Landscape: Oncology vs. Non-Oncology
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/GT-2-1-1.png)
Webinar – The DDR Landscape: The Past, Present & Future
Additional Content
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/ASCO-Infographic-Featured-Images-1.png)
ASCO 2024: Checkpoint Highlights
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-9.png)
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Cytokine-ASCO-Infographic-2024-Featured-Image.png)
ASCO 2024: Cytokine Highlights
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/ASCO-Infographic-Featured-Images.png)
ASCO 2024: ADC Highlights
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/CP-Disease-Landscape-Featured-Image-1.png)
ASCO 2024: Bispecific Highlights
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/CT-2.png)
Webinar – Exploring Allogeneic Cell Therapies: Pioneering Advantages and Recent Innovations
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-5.png)
Beacon Immune Tolerance: 2024 EULAR Annual Meeting Abstracts
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Featured-Images-1-1.png)
Beacon TPD: ASCO Post-Conference Report 2024
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Featured-Images-.png)
Beacon DDR: ASCO Post-Conference Report 2024
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-4.png)
Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/MB-TOI-Digest-Featured-Image.png)
Microbiome: US Market and LBP Development
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/WordPress-Featured-Image-6-e1717692135998.png)
Beacon Oncolytic Viruses: 2024 ASCO Annual Meeting Abstracts
About Beacon
See how our clinical trials and drug database solutions in action
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.